An effective antimicrobial strategy of colistin combined with the Chinese herbal medicine shikonin against colistin-resistant Escherichia coli

Microbiol Spectr. 2023 Dec 12;11(6):e0145923. doi: 10.1128/spectrum.01459-23. Epub 2023 Oct 6.

Abstract

Infections caused by multidrug-resistant Escherichia coli (MDR E. coli) have become a major global healthcare problem due to the lack of effective antibiotics today. The emergence of colistin-resistant E. coli strains makes the situation even worse. Therefore, new antimicrobial strategies are urgently needed to combat colistin-resistant E. coli. Combining traditional antibiotics with non-antibacterial drugs has proved to be an effective approach of combating MDR bacteria. This study investigated the combination of colistin and shikonin, a Chinese herbal medicine, against colistin-resistant E. coli. This combination showed good synergistic antibacterial both in vivo and in vitro experiments. Under the background of daily increasing colistin resistance in E. coli, this research points to an effective antimicrobial strategy of using colistin and shikonin in combination against colistin-resistant E. coli.

Keywords: Escherichia coli; antibiotic resistance; biofilm; colistin-resistant; mcr-1; shikonin; synergistic effect.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Colistin / pharmacology
  • Drugs, Chinese Herbal* / pharmacology
  • Escherichia coli
  • Escherichia coli Infections* / drug therapy
  • Escherichia coli Infections* / microbiology
  • Escherichia coli Proteins* / pharmacology
  • Humans
  • Microbial Sensitivity Tests

Substances

  • Colistin
  • shikonin
  • Drugs, Chinese Herbal
  • Escherichia coli Proteins
  • Anti-Bacterial Agents